Literature DB >> 25519219

Patient self-assessment of flare in rheumatoid arthritis: criterion and concurrent validity of the Flare instrument.

Annette de Thurah1, Thomas Maribo2,3, Kristian Stengaard-Pedersen4.   

Abstract

The French Flare instrument (FI) aims to identify flares in rheumatoid arthritis between consultation. The objective of the present study was to present both concurrent and criterion validity of the Danish version of FI, as compared to DAS28-CRP. The study was a cross-sectional study comparing FI with DAS28-CRP among patients with rheumatoid arthritis (RA) in connection with the same outpatient visit. The study population consisted of 117 prevalent patients diagnosed with RA according to the ACR 1987/2010 criteria. Consecutive patients were included in the study in relation to their outpatient treatment at the Department of Rheumatology, Aarhus University Hospital, Denmark between 01 October 2012 and 31 December 2012. The sensitivity and specificity were 85.4 (95 % CI, 72.2; 93.9) and 50.7 (95 % CI, 38.4; 63.0), respectively. The positive predictive value was 53.6 (95 %CI, 47.0; 60.1) and the negative predictive value 83.9 (95 % CI, 71.7; 91.5). Positive and negative likelihood ratio were 1.73(95 % CI, 1.33; 2.26) and 0.29 (95 % CI, 0.14; 0.59). Tests with high sensitivity and small LR are most useful for ruling out the disease. Hence, our findings indicate that FI works well in ruling out a flare among patients with RA.

Entities:  

Keywords:  Flare; Flare instrument; Patient reported outcome measure; Rheumatoid arthritis; Validation

Mesh:

Year:  2014        PMID: 25519219     DOI: 10.1007/s10067-014-2849-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Diagnostic tests 4: likelihood ratios.

Authors:  Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2004-07-17

2.  How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?

Authors:  Roy Fleischmann; Désirée van der Heijde; Andrew S Koenig; Ronald Pedersen; Annette Szumski; Lisa Marshall; Eustratios Bananis
Journal:  Ann Rheum Dis       Date:  2014-08-20       Impact factor: 19.103

3.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

4.  Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.

Authors:  Elisabeth Lie; Thasia G Woodworth; Robin Christensen; Tore K Kvien; Vivien Bykerk; Daniel E Furst; Clifton O Bingham; Ernest H Choy
Journal:  Ann Rheum Dis       Date:  2013-07-12       Impact factor: 19.103

5.  Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.

Authors:  Kadir Yildirim; Saliha Karatay; Meltem Alkan Melikoglu; Gurhan Gureser; Mahir Ugur; Kazim Senel
Journal:  Ann Clin Lab Sci       Date:  2004       Impact factor: 1.256

6.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

Review 7.  Disease activity measures for rheumatoid arthritis.

Authors:  M Dougados; D Aletaha; P van Riel
Journal:  Clin Exp Rheumatol       Date:  2007 Sep-Oct       Impact factor: 4.473

8.  The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

Authors:  Bonnie Bruce; James F Fries
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

9.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103

10.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Authors:  Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

View more
  6 in total

1.  The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

Authors:  N Barroso; T G Woodworth; D E Furst; F Guillemin; B J Fautrel; N Borazan; S Kafaja; J Brook; D A Elashoff; V K Ranganath
Journal:  Clin Rheumatol       Date:  2019-09-06       Impact factor: 2.980

2.  Ultrasound-detected tenosynovitis as a risk factor for flares in rheumatoid arthritis patients in clinical remission.

Authors:  Johana Zacariaz Hereter; Javier Eduardo Rosa; Florencia Beatriz Mollerach; Josefina Marin; Leandro Gabriel Ferreyra Garrott; Martin Brom; Enrique Roberto Soriano
Journal:  Clin Rheumatol       Date:  2022-02-01       Impact factor: 2.980

3.  The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.

Authors:  Ida Kristiane Roelsgaard; Thordis Thomsen; Mikkel Østergaard; Robin Christensen; Merete Lund Hetland; Søren Jacobsen; Lena Andersen; Hanne Tønnesen; Silvia Rollefstad; Anne Grete Semb; Bente Appel Esbensen
Journal:  Trials       Date:  2017-11-28       Impact factor: 2.279

4.  Fifteen Years' Use of Patient-Reported Outcome Measures at the Group and Patient Levels: Trend Analysis.

Authors:  Niels Henrik I Hjollund
Journal:  J Med Internet Res       Date:  2019-09-30       Impact factor: 5.428

Review 5.  COVID-19: What Do Rheumatologists Need to Know?

Authors:  Gillian E Fitzgerald; Sinead Maguire; Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2021-01-05       Impact factor: 4.592

6.  AmbuFlex: tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases.

Authors:  Liv Marit Valen Schougaard; Louise Pape Larsen; Anne Jessen; Per Sidenius; Liv Dorflinger; Annette de Thurah; Niels Henrik Hjollund
Journal:  Qual Life Res       Date:  2016-01-20       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.